The Anti-Microbial Peptide LL-37/CRAMP Is Elevated in Patients With Liver Diseases and Acts as a Protective Factor During Mouse Liver Injury

Digestion - Switzerland
doi 10.1159/000368304
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Microbial Translocation in Chronic Liver Diseases

International Journal of Microbiology
Microbiology
2012English

Interaction of Antimicrobial Peptide Ll-37 With Lipopolysaccharides

Biophysical Journal
Biophysics
2019English

Actin Enables the Antimicrobial Action of LL-37 Peptide in the Presence of Microbial Proteases

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Antimicrobial Peptide LL-37 Is Bactericidal Against Staphylococcus Aureus Biofilms

PLoS ONE
Multidisciplinary
2019English

Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-Analysis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2013English

The Antimicrobial Peptide, LL-37, Inhibits in Vitro Osteoclastogenesis

Journal of Dental Research
Dentistry
2012English

Evidence of Oxidative Injury During Aging of the Liver in a Mouse Model.

AGE
2001English

Quantitative Analysis of Elevated Serum Golgi Protein-73 Expression in Patients With Liver Diseases

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2009English

The Anti-Microbial Peptide rCRAMP Is Strongly Upregulated During Experimental Arthritis in the Rat

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy